AA, A., T, R., M, J., NN, K., L, B., B, J., . . . ZA, A. (2025). Disruption of Embryogenesis Biomarkers: A Critical Issue for Autism Therapeutics. Developmental neurobiology, 85(3), e22976. https://doi.org/10.1002/dneu.22976
Chicago Style (17th ed.) CitationAA, Al-Dulaimi, et al. "Disruption of Embryogenesis Biomarkers: A Critical Issue for Autism Therapeutics." Developmental Neurobiology 85, no. 3 (2025): e22976. https://doi.org/10.1002/dneu.22976.
MLA (9th ed.) CitationAA, Al-Dulaimi, et al. "Disruption of Embryogenesis Biomarkers: A Critical Issue for Autism Therapeutics." Developmental Neurobiology, vol. 85, no. 3, 2025, p. e22976, https://doi.org/10.1002/dneu.22976.
Warning: These citations may not always be 100% accurate.